Many of our rural communities are saddled with a lot of socioeconomic concerns today, and yet money that should address these concerns and transform their lives are not working
Since IR and compensatory hyperinsulinemia have been considered frequently occurring features of the syndrome, it is now widely recognized that, in addressing and treating the various clinical aspects of PCOS, IR is a problem that needs to be evaluated and solved (4)
In December 2024, it issued warning letters to companies like Prime Peptides, Summit Research Peptides, Swisschems, and Xcel Peptides for promoting unapproved GLP-1 receptor agonists labeled as for research use only. Later, in September 2025, a warning letter to GLP-1 Solution highlighted that compounded retatrutide, semaglutide, and tirzepatide were being sold as unapproved and misbranded drugs
doi: 10.1038/sj.mp.4000919
Beyond absolute reductions in body weight, improvements in insulin sensitivity appear to be a key mechanistic link between metabolic interventions and attenuation of systemic inflammation